Novartis | NOVN - Market Capitalization

Stock Price
118.72
Daily Change
0.02 0.02%
Monthly
6.46%
Yearly
21.50%
Q1 Forecast
111.83

Novartis reported $242.87B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 383.66B 20.17B Feb/2026
Alcon AG USD 29.11B 5.61B Sep/2025
Almirall EUR 2.29B 527.4M Jun/2025
Amgen USD 184.41B 32.48B Feb/2026
AstraZeneca USD 233.07B 17.56B Sep/2025
Autolus Therapeutics Ltd USD 433.81M 172.99M Sep/2025
Bayer EUR 27.23B 2.14B Sep/2025
Biogen USD 20.54B 2.13B Sep/2025
Bristol-Myers Squibb USD 121.04B 29.24B Feb/2026
Eli Lilly USD 1.05T 36.63B Feb/2026
Fresenius EUR 26.7B 2.66B Sep/2025
Fresenius Medical Care EUR 13.1B 1.17B Sep/2025
Galapagos EUR 1.92B 355.84M Sep/2025
Genmab DKK 80.88B 7.82B Jun/2025
Gilead Sciences USD 137.73B 184M Sep/2025
GlaxoSmithKline GBP 87.33B 12.98B Feb/2026
GRIFOLS EUR 7.49B 1.16B Sep/2025
Hikma Pharmaceutical USD 6.06B 1.64B Jun/2025
J&J USD 500.24B 67.44B Dec/2025
Lonza CHF 39.68B 980.61M Jun/2025
Merck EUR 47.59B 239.13M Sep/2025
Merck USD 293.38B 83.74B Feb/2026
Novartis USD 265.66B 9.48B Sep/2025
Novartis USD 303.91B 57.84B Feb/2026
Novo Nordisk A/S DKK 1.54T 86.62B Feb/2026
Orion EUR 9.18B 190.08M Sep/2025
Pfizer USD 147.57B 12.48B Feb/2026
Philips EUR 22.19B 2.53B Sep/2025
Recordati EUR 10.81B 168.23M Sep/2025
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
UCB EUR 32.47B 4.91B Jun/2025